Processing method for raw drug particles of non-uniform particle size
A technology of raw materials and granules, which is applied in the direction of pharmaceutical formulas, medical preparations containing active ingredients, and medical preparations containing active ingredients. Content uniformity and other issues, to achieve the effect of excellent drug content uniformity, easy amplification, and improved fluidity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0078] 200.0 g and Add 35.0 g of crystalline cellulose (KG-1000), 2.5 g of surfactant (solubilizer) powder, and D-mannitol (trade name: Mannit P Mitsubishi Shoji Foodtech Co. Ltd.) 25.0 g, crushing, sizing, and uniform dispersion to obtain 264.0 g of powder for direct compression. This powder was compressed with a tablet press machine (VEL5 type, tablet pressure 14 kN) manufactured by Kikusui Seisakusho to obtain a tablet with a tablet hardness of 119N. In addition, the 15-minute dissolution rate of this tablet was 89%.
[0079] [Ingredient (compounding amount)] [compounding rate (weight%)]
[0080] Pregabalin (200.0g) 74.75%
[0081] (Compared to 100% of pregabalin, 31% of particles larger than 500μm, 14.5% of particles smaller than 60μm)
[0082] Carplex (1.5g) 0.56%
[0083] Broken Whole Grain 1 (Supermasscolloider)
[0084] (Compared to 100% of powder after crushing and sizing 1, 12.5% of particles over 180μm, 1.5% of particles under 60μm)
[0085]
[0086] (Comp...
Embodiment 2
[0088] Use a crushing granulator (Supermasscolloider) to crush and granulate pregabalin powder 300.0g and Carplex 1.6g, which contain 31% of particles above 500 μm and 14.5% of particles below 60 μm, and uniformly disperse them, and add a disintegrant ( L-HPC) 5.0 g, lactose hydrate 22.0 g and polyethylene glycol powder 5.5 g were crushed, sized and uniformly dispersed to obtain 334.1 g of powder. This powder was compressed with a tablet press machine (VEL5 type, tablet pressure 14 kN) manufactured by Kikusui Seisakusho to obtain a tablet with a tablet hardness of 117N. In addition, the 15-minute dissolution rate of this tablet was 89%.
[0089] [Ingredient (compounding amount)] [compounding rate (weight%)]
[0090] Pregabalin (300.0g) 89.8%
[0091] (Compared to 100% of pregabalin, 31% of particles larger than 500μm, 14.5% of particles smaller than 60μm)
[0092] Carplex (1.6g) 0.5%
[0093] Broken Whole Grain 1 (Supermasscolloider)
[0094] (Compared to 100% of powder a...
Embodiment 3
[0099] Add 1.5 g of Carplex and 15.0 g of a disintegrant (L-HPC) to 200.0 g of celecoxib powder containing 32.1% of particles of 500 μm or more and 18.5% of particles of 60 μm or less, and use a crushing and sizing machine ( Supermasscolloider) was crushed, granulated, and uniformly dispersed, and 48.0 g of lactose hydrate, 5.5 g of polyethylene glycol 4000 powder, 9.0 g of HPC-SSL, and 2.0 g of lubricant were added to the obtained powder, and the powder was crushed, sized, and uniformly dispersed. 281.0 g of a powder for direct compression was obtained. This powder was tabletted with a tablet press machine (VEL5 type, tablet pressure 14 kN) manufactured by Kikusui Seisakusho to obtain a tablet with a tablet hardness of 121N. In addition, the 15-minute dissolution rate of this tablet was 91%.
[0100] [Ingredient (compounding amount)] [compounding rate (weight%)]
[0101] Celecoxib (200.0g) 71.2%
[0102] (With respect to celecoxib 100%, 32.1% of particles larger than 500μm...
PUM
| Property | Measurement | Unit |
|---|---|---|
| size | aaaaa | aaaaa |
| size | aaaaa | aaaaa |
| melting point | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


